Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy

Hypertensive retinopathy is seen frequently in patients with systemic hypertension and is usually asymptomatic. An acute rise in blood pressure may lead to exudative changes in the form of macular edema, hemorrhages, and serous macular detachment that can lead to visual decline. The authors report p...

Descripción completa

Detalles Bibliográficos
Autores principales: Padhy, Srikant, Kumar, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173024/
https://www.ncbi.nlm.nih.gov/pubmed/30249851
http://dx.doi.org/10.4103/ijo.IJO_214_18
_version_ 1783361058379923456
author Padhy, Srikant
Kumar, Vinod
author_facet Padhy, Srikant
Kumar, Vinod
author_sort Padhy, Srikant
collection PubMed
description Hypertensive retinopathy is seen frequently in patients with systemic hypertension and is usually asymptomatic. An acute rise in blood pressure may lead to exudative changes in the form of macular edema, hemorrhages, and serous macular detachment that can lead to visual decline. The authors report prompt resolution of exudative changes in a case of hypertensive retinopathy following intravitreal bevacizumab.
format Online
Article
Text
id pubmed-6173024
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-61730242018-10-10 Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy Padhy, Srikant Kumar, Vinod Indian J Ophthalmol Case Reports Hypertensive retinopathy is seen frequently in patients with systemic hypertension and is usually asymptomatic. An acute rise in blood pressure may lead to exudative changes in the form of macular edema, hemorrhages, and serous macular detachment that can lead to visual decline. The authors report prompt resolution of exudative changes in a case of hypertensive retinopathy following intravitreal bevacizumab. Medknow Publications & Media Pvt Ltd 2018-10 /pmc/articles/PMC6173024/ /pubmed/30249851 http://dx.doi.org/10.4103/ijo.IJO_214_18 Text en Copyright: © 2018 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Reports
Padhy, Srikant
Kumar, Vinod
Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
title Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
title_full Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
title_fullStr Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
title_full_unstemmed Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
title_short Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
title_sort dramatic response to intravitreal bevacizumab in hypertensive retinopathy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173024/
https://www.ncbi.nlm.nih.gov/pubmed/30249851
http://dx.doi.org/10.4103/ijo.IJO_214_18
work_keys_str_mv AT padhysrikant dramaticresponsetointravitrealbevacizumabinhypertensiveretinopathy
AT kumarvinod dramaticresponsetointravitrealbevacizumabinhypertensiveretinopathy

Ejemplares similares